Predictors of adherence to treatment in women with fibromyalgia

Clinical Journal of Pain

Volumn 22, Issue 3, 2006, Pages 286-294

  Dobkin, Patricia L ^a,b   Sita, Aurelio ^b   Sewitch, Maida J ^a  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

Adherence; Compliance; Fibromyalgia; Patient physician discordance; Predictors

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; HORMONE; MUSCLE RELAXANT AGENT; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PSYCHOTROPIC AGENT; VITAMIN;

ADULT; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DISTRESS SYNDROME; DOCTOR PATIENT RELATION; FEMALE; FIBROMYALGIA; HEALTH CARE UTILIZATION; HEALTH SERVICE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; PATIENT COMPLIANCE; PRIORITY JOURNAL; TERTIARY HEALTH CARE; TREATMENT REFUSAL; AGED; CANADA; CLINICAL TRIAL; COMORBIDITY; METHODOLOGY; MIDDLE AGED; PAIN; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; STATISTICS; UTILIZATION REVIEW;

ADULT; AGED; COMORBIDITY; FEMALE; FIBROMYALGIA; HEALTH SERVICES; HUMANS; MIDDLE AGED; PAIN; PATIENT COMPLIANCE; PHYSICIAN-PATIENT RELATIONS; PROGNOSIS; QUEBEC; RISK ASSESSMENT; RISK FACTORS;

EID: 33645750853     PISSN: 07498047     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ajp.0000173016.87612.4b     Document Type: Article

References (46)

1. Wolfe F, Smythe HA, Yunus MB. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the multicenter criteria committee. Arthritis Rheum. 1990;33:160-172.
2. Melzack R. Pain and stress: a new perspective. In: Gatchel RJ, Turk DC, eds. Psychosocial Factors in Pain. New York: Raven Press; 1999:89-106.
3. Bennett RM. Fibromyalgia. In: Giamberardino MA, ed. An Updated Review: Refresher Couse. Seattle: IASP Press; 2002:37-49.
4. Gran JT. The epidemiology of chronic generalized musculoskeletal pain. Best Practice & Research Clin Rheumatol. 2003;17:547-561.
5. Robinson RL, Birnbaum HG, Morley MA, et al. Economic cost and epidemiology characteristics of patients with fibromyalgia claims. J Rheumatol. 2003;30:1318-1325.
6. Turk DC, Okijuji EA, Sinclair JD, et al. Interdisciplinary treatment for fibromyalgia syndrome: clinical and statistical significance. Arthritis Care Res. 1998;11:186-195.
7. Vlaeyen J, Teeken-Gruben N, Goossens M, et al. Cognitive-educational treatment of fibromyalgia: a randomized clinical trial. I. Clinical effects. J Rheumatol. 1996;23:1237-1245.
8. Bennett RM. Multidisciplinary group programs to treat fibromyalgia patients. Rheum Dis Clin North Am. 1996;22:351-367.
9. Huyser B, Buckelew SP, Hewett JE, et al. Factors affecting adherence to rehabilitation interventions for individuals with fibromyalgia. Rehabil Psychol. 1997;42:75-91.
10. Sewitch MJ, Dobkin PL, Bernatsky S, et al. Medication non-adherence in women with fibromyalgia. Rheumatology. 2004;43:648-654.
11. Buchwald D. Controversies in fibromyalgia and related conditions. Rheum Dis Clin North Am. 1996;22:219-243.
12. Noble LM. Doctor-patient communication and adherence to treatment. In: Myers LB, Midence K, eds. Adherence to Treatment in Medical Conditions. London, UK: Harwood Academic Publishers; 1998:51-82.
13. Turk DC, Rudy TE. Neglected topics in the treatment of chronic pain patients: relapse, noncompliance, and adherence enhancement. Pain. 1991;44:5-28.
14. Carosella AM, Lackner JM, Feuerstein M. Factors associated with early discharge from a multidisciplinary work rehabilitation program for chronic low back pain. Pain. 1994;57:69-76.
15. Feuerstein M, Theberge RW. Perceptions of disability and occupational stress as discriminators of work disability in patients with chronic pain. J Occup Med. 1991;1:185-195.
16. Barnes D, Smith D, Gatchel RJ, et al. Psychosocioeconomic predictors of treatment success/failure in chronic low back pain patients. Spine. 1989;14:427-430.
17. Hazard RG, Bendix A, Fenwick JW. Disability exaggeration as a predictor of functional restoration outcomes for patients with chronic low back pain. Spine. 1991;14:1062-1067.
18. Davis M, Addis ME. Predictors of attrition from behavioral medicine treatments. Ann Behav Med. 1999;21:339-349.
19. Sherbourne CD, Hays RD, Ordway L, et al. Antecedents of adherence to medical recommendations: results from the Medical Outcomes Study. J Behav Med. 1992;15:447-468.
20. Golin CE, DiMatteo MR, Gelberg L. The role of patient participation in the doctor visit: implications for adherence to diabetes care. Diabetes Care. 1996;19:1153-1164.
21. Sewitch MJ, Dobkin PL, Abrahamowicz M. Effect of discordant physician-patient perceptions on medication adherence in inflammatory bowel disease. Am J Epidemiol. 2001;153:S219.
22. White KP, Harth M, Speechley M, et al. Testing an instrument of screen for fibromyalgia syndrome in general population studies: the London Fibromyalgia Epidemiology Study Screening Questionnaire. J Rheumatol. 1999;26:880-884.
23. Dobkin PL, De Civita M, Abrahamowicz M, et al. Patient-physician discordance in fibromyalgia. J Rheumatol. 2003;30:1326-1334.
24. Penrod JR, Bernatsky S, Adam V, et al. Health service costs and their determinants in women with fibromyalgia. J Rheumatol. 2004;31.
25. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24:67-74.
26. Kravitz RL, Hays RD, Sherbourne CD, et al. Recall of recommendations and adherence to advice among patients with chronic medical conditions. Arch Intern Med. 1993;153:1869-1878.
27. Choo PW, Rand CS, Inui TS, et al. Validation of patient reports, automated pharmacy records and pill counts with electronic monitoring of adherence to antihypertensive therapy. Med Care. 1999;37:846-857.
28. Clarke AE, Esdaile JM, Bloch DA, et al. A Canadian study of the total medical costs for patients with systemic lupus erythematosus and the predictors of costs. Arthritis Rheum. 1993;36:1548-1559.
29. Clarke AE, Petri MA, Manzi S, et al. An international perspective on the well-being and health care costs for patients with systemic lupus erythematosus. J Rheumatol. 1999;26:1500-1511.
30. Clarke AE, Zowall H, Levinton C, et al. Direct and indirect medical costs incurred by Canadian patients with rheumatoid arthritis: a 12-year study. J Rheumatol. 1997;24:1051-1060.
31. Hays RD, Hayashi T, Stewart AL. A five-item measure of socially desirable response set. Educ Psychol Meas. 1989;49:629-636.
32. Melzack R. The McGill Pain Questionnaire: major properties and scoring methods. Pain. 1975;1:277-299.
33. Reading AE. The McGill Pain Questionnaire: an appraisal. In: Melzack R, ed. Pain Measurement and Assessment. New York: Raven Press; 1983:55-61.
34. Sewitch MJ, Abrahamowicz M, Dobkin PL, et al. Measuring differences between patients' and physicians' perceptions: the Patient-Physician Discordance Scale. J Behav Med. 2003;26:245-264.
35. Endler NS, Parker JDA, Summerfeldt LJ. Coping with health problems: developing a reliable and valid multidimensional measure. Psychol Assoc. 1998;10:195-205.
36. Endler NS, Parker JDA. Coping with Health Injuries and Problems (CHIP). Ontario: Multi-Health Systems Inc.; 2000.
37. Hadjistavropoulos HD, Asmundson JG, Norton GR. Validation of the Coping with Health, Injuries, and Problems scale in a chronic pain sample. Clin J Pain. 1999;15:41-49.
38. Derogatis LR. SCL-90-R: Administration, Scoring and Procedures Manual. Minneapolis: National Computer System; 1994.
39. Sarason IG, Levine HM, Basham RB, et al. Assessing social support: the Social Support Questionnaire. J Pers Soc Psychol. 1983;44:127-139.
40. Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika. 1986;73:13-22.
41. Jenrich R, Schluchter M. Unbalanced repeated-measures models with structured covariance matrices. Biometrics. 1986;42:805-820.
42. Dunbar J. Predictors of patient adherence: patient characteristics. In: Shumaker SA, Schron EB, Ockene JK, et al, eds. The Handbook of Health Behavior Change. New York, NY: Springer Pub Co.; 1990:348-360.
43. Kersh BC, Bradley LA, Alarcon GS, et al. Psychosocial and health status variables independently predict health care seeking in fibromyalgia. Arthritis Rheum. 2001;45:362-371.
44. Haynes RB, Taylor DW, Sackett D, et al. Can simple clinical measurements detect patient noncompliance? Hypertension. 1980;2:757-764.
45. DiMatteo MR, Hays RD. Adherence to cancer regimens: implications for treating the older patient. Oncology. 1992;6:50-57.
46. Becker MH, Maimon LA. Strategies for enhancing patient compliance. J Community Health. 1980;6:113-135.